Edward M. Rudnic,James D. Isbister,Donald J. Treacy, Jr.,Sandra E. Wassink
申请号：
US12884050
公开号：
US08303988B2
申请日:
2010.09.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
An antifungal product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antifungal product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
